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The Notch Signaling Pathway drives astrogliogenesis by regulating the 
expression of the transcription factors NFIA and Sox9. 
Derek Janssens · Dr. Merritt Taylor   
Abstract: In the developing nervous system the Notch signaling pathway has recently been 
shown to be necessary and sufficient for neural stem cells to differentiate into astroctyes, a 
process called astrogliogenesis. However, the mechanism of how Notch signaling regulates this 
process has not yet been characterized. Our lab is examining whether Notch signaling controls 
the expression of the genes NFIA and Sox9 which are known to regulate astogliogenesis. These 
candidate genes were selected because their DNA sequences have characteristics that indicate 
their expression could be controlled by Notch through a transcriptional complex of Notch and 
other proteins, including the DNA binding protein RBP/J. We developed a low-cost, effective 
method of qPCR to study the relative abundance of gene expression in mice that underwent 
selective deletion of the RBP/J gene in neural progenitors (including neural stem cells). We 
found that disrupting Notch signaling in neural progenitors of the developing central nervous 
system caused a significant decrease in both NFIA and Sox9 mRNA expression. In order to 
ensure that this trend was reflected at the protein level we performed fluorescence microscopy 
utilizing antibodies targeting the NFIA protein. To determine if Notch directly regulates NFIA 
and Sox9 expression we are currently optimizing a Chromatin immuno-Precipitation assay to 
establish whether the Notch-RBP/J transcriptional complex binds to the NFIA and Sox9 promoter 
regions that are important to drive their expression. These novel findings offer insight into this 
putative signaling pathway, advancing our understanding of how neural stem cell differentiation 
is regulated. 
Keywords: Gliogenesis, Notch Signaling Pathway, NFIA, Sox9, qPCR home-mix. 
Introduction: 
During development neural progenitors, including neural stem cells, are capable of dividing 
and maturing, or differentiating, into the variety of cells that make up an organism. An important 
question in stem cell biology is how these cells coordinate the differentiation and development of 
tissues and organ systems at precisely the right time and place. In the developing central nervous 
system (CNS) neural stem cells (NSCs) are responsible for giving rise to several kinds of specialized 
tissue including neurons, and glia or astrocytes (a specific type of glia). During the early stages of the 
formation of the CNS neural stem cells reside mainly in the ventricular zone and preferentially give 
birth to neurons (neurogenesis). As development progresses these stem cells begin to undergo glial-
fate specification and migrate outward, predominantly giving rise to glia (gliogenesis). The Notch 
signaling pathway is known to have multiple critical roles in the regulation of NSCs throughout this 
neurogenic to gliogenic “switch.” The Notch receptor, which spans the plasma membrane, is 
activated by ligands such as Delta 1. Upon ligand binding, an inner cellular fragment of the receptor 
known as the Notch intercellular domain (NICD) is cleaved and translocates to the nucleus where it 
binds to its transcriptional cofactor RBP/J (a DNA binding protein). The Notch-RBP/J complex then 
binds to the promoter region of a variety of different genes and drives their expression. Prior to and 
during neurogenesis the Notch signaling pathway functions to regulate stem cell maintenance by 
directly regulating the expression of Hes transcriptional repressor genes (Ohtsuka et al. 1999). The 
Hes genes inhibit proneural genes such as neurogenins (reviewed in Louvi and Artavanis-Tsakonas, 
2006 ) and allow NSCs to undergo asymmetric division, simultaneously giving rise to neurons as 
well as more NSCs. Conversely, later in development the Notch signaling pathway is both necessary 
and sufficient to promote NSC differentiation into astroctyes and peripheral glia in the central and 
peripheral nervous systems (Taylor et al. 2007, Morrison et al. 2000).  The mechanism of how Notch 
regulates this process has not yet been characterized. Although the up-regulation of the Hes genes 
has been shown to promote gliogenesis in the retina (Hojo et al. 2000), similar experiments 
examining the role of Hes 1 and Hes 5 in the developing spinal cord found that the misexpression of 
these genes alone is not sufficient to promote gliogenesis in the spinal cord (Ohtsuka et al. 2001). 
This indicates that Notch regulates the expression of an alternative astrogliogenic gene in the 
developing CNS.  
In order to address this issue we compiled a list of genes known to be involved in the 
regulation of astrogliogenesis. The transcription factor NFIA has been shown to promote glial-fate 
specification in the ventricular zone during early astrogliogenesis, and to promote the terminal 
differentiation of progenitors into astrocytes later in development (Deneen et al. 2006), the loss of 
NFIA expression has been shown to result in a loss of glial cells in the ventricular zone (Deneen et 
al. 2006) similar to results seen when Notch signaling is disrupted just prior to astrogliogenesis 
(Taylor et al., 2007). These observations suggest that NFIA could be a novel effector of Notch 
regulated gliogenesis. A second transcription factor Sox9 is also necessary for astrogliogenesis in the 
CNS and functions to regulate the proper timing of glial differentiation (Stolt, et al. 2003). Loss-of-
function studies have shown that disrupting Notch signaling in neural progenitors results in a loss of 
Sox9 expression (Taylor et al. 2007). However, it was not shown whether Notch regulates Sox9 gene 
directly. We sought to define a more complete expression profile of Sox9 in order to establish if it is 
indeed directly regulated by the Notch signaling pathway. Using a bio-informatic approach we 
identified putative binding sites of the Notch-RBP/J complex on the promoter region of both NFIA 
and Sox9. This information establishes the possibility of a direct link between Notch signaling and 
these two astrogliogenic genes.  
To determine if Notch signaling is necessary for NFIA and Sox9 expression, we conditionally 
deleted Rbpsuh from NSC in the developing nervous system in mice.  To assay the gene expression in 
the mutant mice, we developed a low-cost effective approach using quantitative PCR to measure mRNA 
expression, and standard immunohistochemical techniques for protein expression.  We found that 
disruption of Notch signaling by deletion of the Rbpsuh gene significantly decreased the expression of 
the proastrocyte genes NF1A and Sox9.  Thus these genes are likely effectors of Notch signaling known 
to regulate astrogliogenesis. 
 
Materials and Methods 
Mice 
Mice were housed in the animal facilities at Grand Valley State University. The care and treatment of 
these animals followed those outlined in Application for Animal Use in Research or Teaching and 
were approved by the Grand Valley State University’s Institutional Animal Care and Use Committee 
(IACUC). All animals used in this study were genotyped with PCR on genomic DNA to verify 
whether tissue samples contained the Rbpsuh gene deletion. The Cre insert gene was amplified using 
forward primer ATTGCTGTCACTTGGTCGTGG and reverse primer 
GAAAATGCTTCTGTCCGTTTGC. In Nestin-Cre tissue this reaction yields a 210 bp product. For 
detection of the wild type Rbpsuh (Rbpsuh wt) allele reactions contained forward primer 
GTTCTTAACCTGTTGGTCGGA and reverse primer GCTTGAGGCTTGATGTTCTGTAATGC 
yielding a 487 bp PCR product. To detect the Rbpsuh floxed (Rbpsuh fl) inserts on the Rbpsuh allele 
the forward primer GCAATCCATCTGTTCAATGGCC and reverse primer 
GAAGGTCGGTTGACACCAGATAGC were used, these primers yield a 598bp product. Samples in 
which the PCR reactions were positive for Nestin-Cre and showed that both Rbpsuh alleles were 
floxed (Rbpsuh fl/fl) qualified as Rbpsuh cKO tissue. Tissue samples extracted from animals of all 
other genotypes were used as control tissue: the Cre insert alone, Rbpsuh fl/fl alone, or Cre insert 
along with the Rbpsuh fl/wt heterozygote have never been observed to deviate from the wild type 
phenotype.  
 
Total RNA Isolation and cDNA Generation 
Tissue was obtained from the developing nervous system at a variety of different developmental time 
points from both Nes-Cre+ Rbpsuh fl/fl mice and wild type mice. This tissue was then dissociated and 
a cell count was determined using a hemocytometer. 18,000 to 90,000 cells of the extracted tissue 
was then added to TriZol and stored at -800C. Once thawed, glycogen was added to the TriZol before 
separating the solution into an aqueous and organic layer in order to increase the yield of RNA. 
Chloroform was then added to the solution and it was centrifuged at 10,500 rpm for 15min at -40C. 
The top aqueous layer was then transferred to an RNase free microcentrifuge tube and 500  L of 
Isopropanol was added to precipitate the RNA. The solution was centrifuged at 10,500 rpm for 15 
minutes at -40C and the supernatant was removed. The RNA pellet was then washed with 1000 L of 
80% ice cold ethanol and centrifuged again at 8,500 rpm for 15 minutes at -40C. Again the 
supernatant was removed and the pellet was allowed to air dry. The RNA was then resuspended in 
Nuclease free H2O and treated with RQ-1 RNase-Free DNase (Promega, Madison, WI). 80 units of 
RNaseOUT™ Recombinant Ribonuclease Inhibitor (Invitrogen). RNA clean up was preformed using 
an RNeasy Mini Kit (Qiagen) following manufacturer’s specifications with two exeptions (1) the 
initial flow-through of the RLT-BME-Ethanol buffer was saved and run through the column a second 
time, and (2) a second 30  L of H2O was added to the column to increase the RNA elution yield. 
The total RNA was then treated with random primers and Multiscribe Reverse Transcriptase 
(Applied Biosystems) in order to generate cDNA. This solution was diluted in H20 to a concentration 
of 100 cells/ L to be used for qPCR. All cDNA solutions were stored at -200C.    
 
Quantitative Polymerase Chain Reaction 
A low cost effective qPCR mix was developed. Our final reaction mix consisted of 0.15  L or 0.75 
Units of HotStar Taq Plus DNA Polymerase (Qiagen), 2 L 10X Hot start buffer containing 15mM 
MgCl2, 2 L of solution containing 10mM each dNTP, 2.4  L of 25 mM MgCl2, 1  L SYBR green 
I (Invitrogen) working stock prepared by a dilution series of 1:100 in DMSO then 1:50 in H20 (final 
dilution of 1:100,000). 2 L of 5uM Forward primer solution and 2 L of 5 M Reverse primer 
solution were added to the reaction mix along with 2 L of cDNA solution (100cells / L), the 
appropriate amount of H20 was then added for a final reaction volume of 20  L. Optical 8X tube 
strips were used with Optical 8X cap strips (Stratagene). Initial denaturation was carried out at 950C 
for 5 minutes, followed by 40 cycles of 950C for 30seconds, 580C for 30seconds, and 720C for 
30seconds. A dissociation curve was run following each reaction. The NFIA gene was amplified 
using the forward primer AAGCCTCCAACCACATCAAC and the reverse primer 
TTTACAAAGCTTGGATCCCG, this reaction amplifies a product 124 base pairs in length. The 
Sox9 gene was amplified using the forward primer AGGAAGCTGGCAGACCAGT and the reverse 
primer CGAAGGGTCTCTTCTCGCT, this reaction amplifies a product 102 base pairs in length.  -
actin was used as the normalizer gene and was amplified with the forward primer 
GATATCGCTGCGCTGGTCGTC and the reverse primer TCTCTTGCTCTGGGCCTCGTCAC, 
this reaction produces a 176 bp product. The efficiency of these reactions was tested using a cDNA 
serial dilution and determined to be within the acceptable range 90-110%. All reactions were carried 
out using the Mx3000p qPCR machine (Stratagene).           
 
Immunohistochemistry and tissue preparation 
The spinal cords of e18.5 embryos were dissected and fixed in 4% paraformaldehyde overnight. The 
fixed neural tissue was then washed in PBS, cryoprotected in 15% sucrose, and mounted in Tissue-
Tek OCT (VWR, West Chester, PA) prior to snap-freezing and sectioning into 12 m sections. 
Tissue sections were collected using a Leica cryostat and mounted on glass slides. Tissue slides were 
stored at -800C.     
 Tissue sections were blocked in modified GSS (PBS containing 5% goat serum and 0.5% 
Triton X-100). The primary antibody targeting NFIA, NF-1A pAb (Active Motif), was diluted 
1:2000 in modified GSS and applied to the neural tissue slide followed by a cover slip. This was 
allowed to incubate overnight at 40C. The tissue sections were then washed and a diluted 1:500 of 
Cy3 goat anti rabbit antibody (Jackson Immunoresearch, Baltimore) was applied and incubated for 1 
hour at room temperature. Nuclei were counterstained with 2.5  g/ml DAPI for 10 minutes at room 
temperature and then mounted using ProLong antifade solution (Molecular Probes, Eugene, OR).  
 
Results 
To determine if Notch signaling is necessary for NFIA and Sox9 expression the first step was 
to establish if disrupting Notch signaling causes a loss of NFIA expression. The complete loss-of- 
function of Notch signaling, such as in the case of Notch1 or Rbpsuh deletion, results in premature 
neural differentiation and depletion of the progenitor pool (Lutof et al., 2002) prior to the onset of 
astrogliogenesis. This makes these animals unsuitable for investigating the role of Notch signaling in 
both the early and late stages of astrocyte differentiation. To circumvent this issue we used a Cre-
recombinase-LoxP conditional gene deletion approach in mice.  Mutant mice (described as Rbpsuh 
cKO or Rbpsuh conditional knockout mice) express Cre recombinase under a Nestin promoter, 
which drives expression of Cre recombinase in neural stem cells in the developing central nervous 
system.  These mutant mice also have recognition sites for Cre recombinase engineered in the exons 
for the gene Rbpsuh, which encodes the RBP/J protein.  When Cre recombinase is expressed in 
NSCs of Rbpsuh cKO mice, it excises the Rbpsuh gene so that it can no longer be expressed and 
disrupts the formation of the Notch transcriptional complex and Notch signaling.  Gene deletion in 
NSCs occurs shortly before astrogliogenesis begins, thus blocking all canonical Notch signaling in 
these NSCs, and rendering them unable to undergo astrogliogenesis (Taylor et al., 2007).  
We used the quatitative Polymerase Chain Reaction (qPCR) to compare the relative abundance of 
NFIA and Sox9 gene expression in the Rbpsuh cKO mice to control littermates. We found that the 
conditional deletion of the gene Rbpsuh from NSCs of the CNS results in a decrease in the amount of 
NFIA and Sox9 expression at all stages of astrogliogenesis. The data obtained from qPCR shows that at 
E14.5 NFIA expression is 60% that of the control (sd 12%). At E15.5 the expression of NFIA in cKO 
mice is 19.15% that of the control (sd 0.46%) and at E.19.5 NFIA expression is 42.5 % that of the control 
(sd 4.95%). In the Rbpsuh cKO mice Sox9 expression is 49% that of the control (sd 3%). At E15.5 it is 
12.30% that of the control (sd 0.99%) and at E 19.5 Sox9 expression is 38.5 % of the control (sd 3.54%) 
(Figure 1). The results obtained from the qPCR analysis of Sox9 expression at early stages of 
astrogliogenesis in Rbpsuh cKO mice where consistent with previous findings (Taylor et al. 2007).       
The immunofluorescence assay 
of NFIA protein expression 
showed that at E18.5 fewer 
cells expressed NFIA in the 
Rbpsuh cKO mice then in the 
control mice. As expected in the 
control condition cells staining 
positive for NFIA were 
concentrated in the regions in 
which astocytes arise, dorsal to 
the ventricular zone surrounding 
the neural tube and radiating 
outward from this position to 
both the left and right ventral 
horns of the CNS. In the spinal 
cords of the cKO mice there is a 
striking decrease in the number 
Figure 1: The conditional KO of RBP/J 
in NSC results in a decrease in the 
relative abundance of both NFIA and 
Sox9 mRNA expression in the 
developing CNS 
(A) qPCR analysis of NFIA mRNA 
expression in developing neural tube of 
Rbpsuh cKO mice as compared to the 
control. Three different stages of 
astrogliogenesis were assessed  
(Early = E14.5, Middle = E15.5 and 
Late = E19.5) N = 2 for all stages of 
astrogliogenesis.     
(B) qPCR analysis of Sox9 mRNA 
expression in developing neural tube of 
Rbpsuh cKO mice as compared to the 
control. Three different stages of 
astrogliogenesis were assessed  
(Early = E14.5, Middle = E15.5 and 
Late = E19.5) N=2 for all stages of 
astrogliogenesis.     
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Figure 2: The conditional KO of RBP/J in NSCs results in a 
decrease in the relative abundance of NFIA protein expression 
primarily in the regions surrounding the neural tube. These 
images show a transverse cross section of the E18.5 developing 
spinal cord stained with an antibody targeting NFIA. 
 
of cells that are brightly stained for NFIA in the region surrounding the neural tube (which has 
collapsed, a trait common to this model) as well as the ventral regions of the CNS (Figure 2). 
We found that blocking Notch signaling results in a significant decrease of both NFIA and 
Sox9 expression in the developing CNS at all stages of astrogliogenesis prior to birth. Pups born with 
this mutation die at birth, so later time-points could not be tested.  
 
Discussion 
These findings indicate that Notch signaling is necessary for the expression of both NFIA and 
Sox9 at multiple stages of astrogliogenesis in the developing CNS (Figs. 1 & 2), unveiling a new 
function of the Notch signaling pathway. However, it is not know whether Notch directly or 
indirectly regulates the expression of these genes. Notch could regulate a signaling cascade which in 
turn regulates NFIA and Sox9 expression. We are currently performing a Chromatin Immuno-
precipitation assay to determine if the Notch-RBP/J complex directly drives NFIA and Sox9 
expression by binding to the promoter region of these genes at sites identified by our bioinfomatic 
approach. These ongoing experiments will determine how Notch regulates these astrogliogenic 
genes.   
The results of this study provide evidence in support of a unitary mechanism that regulates 
the neurogenic to gliogenic “switch” of NSCs in developing spinal cord. Currently two separate 
theories of how this process is regulated exist. The first is that developing neuroblasts present Notch 
ligand feedback signals that activate Notch signaling in the surrounding NSCs and promote 
differentiation into glia (Morrison et al. 2000). This theory garnered support from the finding that 
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Figure 3: Various models explaining the regulation 
of the neurogenic to gliogenic “switch” in NSCs. 
(A) Notch regulates the maintenance of the NSCs 
(S) and inhibits the formation of neurons (N) by 
promoting Hes 5. Notch drives the differentiation 
of NSCs into glia (G) through an unknown 
mechanism. 
(B) Both Notch and NFIA are necessary for Hes 5 
expression and NFIA drives gliogenesis. 
(C) Notch regulates Hes5 directly and indirectly 
due to its necessity for NFIA, and promotes 
gliogenesis through the regulation of NFIA either 
directly or indirectly.      
  
disruption of Notch signaling “in vivo” results in a severe defect of astrogliogenesis (Taylor et al., 
2007) indicating that Notch is both necessary and sufficient for glial differentiation (Figure 3 (A)). A 
second explanation is that the Notch signaling pathway and its effectors function to suppress 
neurogenesis, while the NFIA gene, in conjunction with another transcription factor NFIB, promote 
glia-fate specification (Deneen et al., 2006). Interestingly, it has been found that NFIA is also 
required for the inhibition of neurogenesis due to its necessity for the maintenance of the Notch 
effector Hes5 (Deneen et al. 2006) (Figure 3 (B)). While these two explanations of the “switch” of 
NSCs to glial lineages could exist contemporaneously, our data suggest that they are in the same 
pathway (Figure 3 (C)).  
These findings may also yield insight into several pathologies that afflict the nervous system 
including multiple sclerosis, and the glial scarring that is associated with damage to the spinal cord. 
Both of these pathologies have been linked to an astrocyte hypertrophy (John et al., 2002, Ridet et al 
1997) making the Notch signaling pathway and its effectors potential targets for novel therapies. 
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